Wall St Price Targets

OBIO Price Forecast
Based on 9 analysts

+96% Upside
from $5.73 today

Orchestra Biomed Holdings Inc (OBIO)’s 12-month stock price forecast through November 2027 has a consensus target of $11.22, implying 96% upside. The forecast is based on price targets from 9 Wall Street analysts.

OBIO Analyst Rating
Based on 7 analysts

avg. 4.86 of 5
Strong buy
6 86%
Buy
1 14%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate OBIO Strong buy, with 7 of 7 recommending Buy or Strong buy.

Orchestra Biomed Holdings Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OBIO's stock price target?
Price Target
11.22 USD

According to Wall Street analysts, the average 1-year price target for OBIO is 11.22 USD with a low forecast of 9.09 USD and a high forecast of 21 USD.

What is the Revenue forecast for Orchestra Biomed Holdings Inc?
Projected CAGR
29%

The compound annual growth rate for Revenue over the next 8 years is 29%.

What is the Gross Profit forecast for Orchestra Biomed Holdings Inc?
Projected CAGR
28%

The compound annual growth rate for Gross Profit over the next 8 years is 28%.

Back to Top